| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Serdar Bulun | Q22277212 |
| Takeshi Kurita | Q56065739 | ||
| P2093 | author name string | J Julie Kim | |
| P2860 | cites work | Hormonal therapy in advanced or recurrent endometrial cancer | Q24235543 |
| Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells | Q24338931 | ||
| Retinoid-binding proteins: mediators of retinoid action | Q24532058 | ||
| The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis | Q24542480 | ||
| Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B | Q24556548 | ||
| Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene | Q24561849 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2 | Q24602570 | ||
| Steroid receptor induction of gene transcription: a two-step model | Q24684065 | ||
| Transforming growth factor-beta and breast cancer: Mammary gland development | Q24793194 | ||
| Cancer of the endometrium: current aspects of diagnostics and treatment | Q24797130 | ||
| A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator | Q27644049 | ||
| The nuclear receptor superfamily: the second decade | Q27860725 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters | Q28116725 | ||
| Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity | Q28139613 | ||
| The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development | Q28142247 | ||
| Progesterone antagonists and progesterone receptor modulators: an overview | Q28190655 | ||
| Classification and pharmacology of progestins | Q28190957 | ||
| Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women | Q28217820 | ||
| Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas | Q72836831 | ||
| Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells | Q73025327 | ||
| In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism | Q73027724 | ||
| Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells | Q73047830 | ||
| Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group | Q73181479 | ||
| Prediction of pregnancy in infertile women based on the American Society for Reproductive Medicine's revised classification of endometriosis | Q73296563 | ||
| Mammary gland development is mediated by both stromal and epithelial progesterone receptors | Q73386750 | ||
| Endometriosis-associated pelvic pain: evidence for an association between the stage of disease and a history of chronic pelvic pain | Q73476608 | ||
| Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40 | Q73645480 | ||
| Correlation between shrinkage of uterine leiomyoma treated with buserelin acetate and histopathologic findings of biopsy specimen before treatment | Q73814534 | ||
| Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures | Q74011770 | ||
| Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform | Q74281193 | ||
| Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis | Q74393765 | ||
| Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis | Q74439718 | ||
| Steroid receptor expression in endometria from women treated with tamoxifen | Q77310474 | ||
| Involvement of cyclin-dependent kinase inhibitor p27Kip1 in growth inhibition of endometrium in the secretory phase and of hyperplastic endometrium treated with progesterone | Q77449008 | ||
| Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol | Q77676838 | ||
| Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland | Q77882685 | ||
| Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function | Q78257311 | ||
| Low-dose mifepristone for uterine leiomyomata | Q78952409 | ||
| Progestational agents in the treatment of carcinoma of the endometrium | Q79032134 | ||
| R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism | Q79455934 | ||
| A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata | Q79791604 | ||
| The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata | Q79879853 | ||
| Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5' CpG island in endometriosis | Q80370190 | ||
| Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas | Q81795348 | ||
| Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment | Q82692784 | ||
| Endometriosis | Q83187897 | ||
| Progesterone receptors (PR)-B and -A regulate transcription by different mechanisms: AF-3 exerts regulatory control over coactivator binding to PR-B | Q83954270 | ||
| Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths | Q28241157 | ||
| Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications | Q28241710 | ||
| Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis | Q28247308 | ||
| Clinical utility of progesterone receptor modulators and their effect on the endometrium | Q28252030 | ||
| The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation | Q28266607 | ||
| A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A | Q28285192 | ||
| A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells | Q28296171 | ||
| 17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium | Q28369073 | ||
| Genistein effects on stromal cells determines epithelial proliferation in endometrial co-cultures | Q28388428 | ||
| Cellular expression of estrogen and progesterone receptors in mammary glands: regulation by hormones, development and aging | Q28506750 | ||
| Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform | Q28586470 | ||
| Hepatocyte growth factor is required for progestin-induced epithelial cell proliferation and alveolar-like morphogenesis in serum-free culture of normal mammary epithelial cells | Q28592980 | ||
| Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells | Q28771752 | ||
| Retinoid-binding proteins: mediators of retinoid action | Q29038601 | ||
| Molecular mechanisms of action of steroid/thyroid receptor superfamily members | Q29547540 | ||
| Nuclear receptor coregulators: cellular and molecular biology | Q29547588 | ||
| Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression | Q29614274 | ||
| Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities | Q29615568 | ||
| Gene regulation by steroid hormones | Q29618291 | ||
| The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle | Q30159541 | ||
| Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases | Q30167936 | ||
| Coordinated regulation of HOX gene expression in myometrium and uterine leiomyoma | Q30868227 | ||
| Management of uterine leiomyomata: what do we really know? | Q31094995 | ||
| 17-beta estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway | Q31911939 | ||
| Stromal-epithelial interactions modulate estrogen responsiveness in normal human endometrium | Q32023693 | ||
| Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors | Q33315228 | ||
| Estrogen, DNA damage and mutations | Q33538106 | ||
| The genetics of endometriosis | Q33595680 | ||
| Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells | Q33658348 | ||
| Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. | Q33733718 | ||
| Retinoic acid: its biosynthesis and metabolism | Q33743830 | ||
| Progesterone: the ultimate endometrial tumor suppressor. | Q33773307 | ||
| Stromal deletion of the APC tumor suppressor in mice triggers development of endometrial cancer | Q33833367 | ||
| Novel mechanisms of progesterone antagonists and progesterone receptor | Q33872590 | ||
| Progesterone is essential for maintenance and growth of uterine leiomyoma. | Q33874391 | ||
| Theories of endometrial carcinogenesis: a multidisciplinary approach | Q33886758 | ||
| Steroid hormone receptor status of mouse mammary stem cells | Q42498451 | ||
| Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas. | Q42514799 | ||
| Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis | Q42522100 | ||
| A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. | Q42623460 | ||
| Treatment of recurrent or metastatic low-grade endometrial stromal sarcoma: three case reports | Q42742743 | ||
| Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2. | Q42823263 | ||
| Control of mammary stem cell function by steroid hormone signalling. | Q43103606 | ||
| Hormone-responsive model of primary human breast epithelium | Q43236099 | ||
| Regression of uterine leiomyomata in response to the antiprogesterone RU 486. | Q43451349 | ||
| Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. | Q43540226 | ||
| Molecular tools to reestablish progestin control of endometrial cancer cell proliferation. | Q43575608 | ||
| Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system | Q43583220 | ||
| Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells | Q43805305 | ||
| Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. | Q43878482 | ||
| Effect of different doses of progestin on uterine leiomyomas in postmenopausal women. | Q43957492 | ||
| Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium | Q44101817 | ||
| Proliferative activity of human uterine leiomyoma cells as measured by automatic image analysis | Q44104200 | ||
| Effect of hormone replacement therapy on uterine fibroids in postmenopausal women--a 3-year study | Q44149062 | ||
| Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES). | Q44173042 | ||
| A novel LacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development. | Q44196804 | ||
| Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12-dimethylbenz[a]anthracene-induced hormone-independent preneoplastic lesions in vitro | Q44198306 | ||
| Progestin suppresses matrix metalloproteinase production in endometrial cancer | Q44416775 | ||
| Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility | Q44480597 | ||
| Progesterone receptors A and B differentially affect the growth of estrogen-dependent human breast tumor xenografts | Q44503512 | ||
| Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen. | Q44542327 | ||
| Steroid receptor and aromatase expression in baboon endometriotic lesions | Q44593824 | ||
| Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study | Q44747918 | ||
| Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells | Q44807399 | ||
| Reduction of apoptosis and proliferation in endometriosis | Q44966171 | ||
| Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases | Q45172178 | ||
| A novel organotypic culture model for normal human endometrium: regulation of epithelial cell proliferation by estradiol and medroxyprogesterone acetate | Q45234417 | ||
| Hormone receptor patterning plays a critical role in normal lobuloalveolar development and breast cancer progression | Q45248775 | ||
| A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms | Q45352912 | ||
| Sex steroidal modulation of collagen metabolism in uterine leiomyomas. | Q46033596 | ||
| The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study | Q46095985 | ||
| Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect | Q46198980 | ||
| Stromal progesterone receptors mediate the inhibitory effects of progesterone on estrogen-induced uterine epithelial cell deoxyribonucleic acid synthesis | Q46200500 | ||
| Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis | Q46212864 | ||
| Treatment of endometriosis with the antiprogesterone mifepristone (RU486) | Q46235118 | ||
| In situ localization of progesterone receptors in normal mouse mammary glands: absence of receptors in the connective and adipose stroma and a heterogeneous distribution in the epithelium | Q46355922 | ||
| Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development | Q46477275 | ||
| The effect of mifepristone on breast cell proliferation in premenopausal women evaluated through fine needle aspiration cytology | Q46519248 | ||
| Upregulation of ATP-sensitive potassium channels for estrogen-mediated cell proliferation in human uterine leiomyoma cells | Q46527809 | ||
| The activation function-1 domain of estrogen receptor alpha in uterine stromal cells is required for mouse but not human uterine epithelial response to estrogen. | Q46683753 | ||
| Progestin treatment induces apoptosis and modulates transforming growth factor-beta in the uterine endometrium | Q46694719 | ||
| Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer | Q46748582 | ||
| The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells | Q46930093 | ||
| Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma | Q46974271 | ||
| In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells | Q46981297 | ||
| Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial | Q47311848 | ||
| The nuclear receptor superfamily | Q35049890 | ||
| Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis | Q35097256 | ||
| Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action. | Q35108292 | ||
| Mouse primary uterine cell coculture system revisited: ovarian hormones mimic the aspects of in vivo uterine cell proliferation | Q35110813 | ||
| The role of progesterone signaling in the pathogenesis of uterine leiomyoma | Q35249360 | ||
| Uterine leiomyoma in the Eker rat: a unique model for important diseases of women. | Q35563119 | ||
| Stop! In the name of transforming growth factor-beta: keeping estrogen receptor-alpha-positive mammary epithelial cells from proliferating | Q35605773 | ||
| Effect of infertility treatment and pregnancy-related hormones on breast cell proliferation in vitro | Q35620770 | ||
| Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis. | Q35654201 | ||
| The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors | Q35671179 | ||
| Is insulin resistance an essential component of PCOS?: The endometriosis syndromes: a clinical classification in the presence of aetiological confusion and therapeutic anarchy | Q35700490 | ||
| Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models | Q35749425 | ||
| HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm | Q35763527 | ||
| Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function | Q35787724 | ||
| Estrogen receptor-positive proliferating cells in the normal and precancerous breast. | Q35787982 | ||
| Systematic review of mifepristone for the treatment of uterine leiomyomata | Q35789745 | ||
| Progesterone receptor distribution in the human endometrium. Analysis using monoclonal antibodies to the human progesterone receptor | Q35818398 | ||
| The biology of progesterone receptor in the normal mammary gland and in breast cancer | Q35868802 | ||
| Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. | Q35895916 | ||
| Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation | Q35911329 | ||
| Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors | Q35940872 | ||
| Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies | Q36029584 | ||
| Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis | Q36062838 | ||
| A paracrine role for the epithelial progesterone receptor in mammary gland development | Q36064196 | ||
| Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. | Q36113833 | ||
| Aromatase, breast cancer and obesity: a complex interaction | Q36191587 | ||
| Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium | Q36193533 | ||
| Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. | Q36234570 | ||
| Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis | Q36364699 | ||
| Progesterone resistance in endometriosis: link to failure to metabolize estradiol | Q36365708 | ||
| The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk | Q36465880 | ||
| Transcription activation by estrogen and progesterone receptors | Q36468309 | ||
| The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma | Q36513184 | ||
| Volume change of uterine myomas during pregnancy: do myomas really grow? | Q36589882 | ||
| Molecular mechanisms involved in progesterone receptor regulation of uterine function | Q36635728 | ||
| Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism | Q36661971 | ||
| Etiology, symptomatology, and diagnosis of uterine myomas | Q36790210 | ||
| Hormone therapy in advanced and recurrent endometrial cancer: a systematic review | Q36794868 | ||
| Progesterone receptors in the mouse mammary duct: distribution and developmental regulation. | Q36819985 | ||
| The emerging picture of the mouse mammary stem cell | Q36943334 | ||
| Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives | Q36981305 | ||
| Tumor stroma and regulation of cancer development | Q37014752 | ||
| Transcriptional response of the murine mammary gland to acute progesterone exposure | Q37034915 | ||
| Serial histologic observation of endometrial adenocarcinoma treated with high-dose progestin until complete disappearance of carcinomatous foci--review of more than 25 biopsies from five patients | Q37064497 | ||
| Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts | Q37150735 | ||
| Progestins activate the AKT pathway in leiomyoma cells and promote survival. | Q37198021 | ||
| Mechanical homeostasis is altered in uterine leiomyoma | Q37227767 | ||
| DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast | Q37244666 | ||
| Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms | Q37302387 | ||
| A novel organotypic model mimics the tumor microenvironment | Q37316568 | ||
| A low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells | Q37323351 | ||
| Low-grade endometrial stromal sarcoma of the uterus: review of 10 cases. | Q37334288 | ||
| Progesterone receptor action in leiomyoma and endometrial cancer | Q37338412 | ||
| Progestin receptors: isoforms and antihormone action | Q37544485 | ||
| Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells | Q37577169 | ||
| Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved | Q37823119 | ||
| Endometrial hyperplasia | Q37838975 | ||
| Cracking the estrogen receptor's posttranslational code in breast tumors | Q37890710 | ||
| Recent advances in endometrial cancer | Q38013633 | ||
| Global gene profiling in human endometrium during the window of implantation | Q38289149 | ||
| RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism. | Q38308917 | ||
| Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. | Q38319428 | ||
| The progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex | Q38342253 | ||
| In utero exposures and the incidence of endometriosis | Q38476122 | ||
| Reproductive history and endometriosis among premenopausal women | Q38476734 | ||
| 'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis | Q39276875 | ||
| Progestins for symptomatic endometriosis: a critical analysis of the evidence. | Q39453269 | ||
| Normal endometrial stromal cells regulate survival and apoptosis signaling through PI3K/AKt/Survivin pathway in endometrial adenocarcinoma cells in vitro | Q39499928 | ||
| Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma | Q47976455 | ||
| Endometriosis rediscovered? | Q48656840 | ||
| Human 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression and localization in term placenta and in endometrium during the menstrual cycle. | Q50896417 | ||
| Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures. | Q50944536 | ||
| Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. | Q50970377 | ||
| Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone. | Q50981405 | ||
| Effects of sex steroids and growth factors on migration and invasion of endometrial adenocarcinoma SNG-M cells in vitro. | Q51031691 | ||
| Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy. | Q51060775 | ||
| Selective release of follicle-stimulating hormone and luteinizing hormone by 5 alpha-dihydroprogesterone and 3 alpha, 5 alpha-tetrahydroprogesterone in pregnant mare's serum gonadotropin-primed immature rats exposed to constant light. | Q51827600 | ||
| Transcriptional cross talk between the forkhead transcription factor forkhead box O1A and the progesterone receptor coordinates cell cycle regulation and differentiation in human endometrial stromal cells. | Q51981689 | ||
| Dissociation between steroid receptor expression and cell proliferation in the human breast. | Q52528046 | ||
| Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat. | Q52541425 | ||
| Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. | Q52571111 | ||
| Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17beta-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism. | Q52578119 | ||
| Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen. | Q53407664 | ||
| Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. | Q53541411 | ||
| Endometriosis | Q55951108 | ||
| Ultrastructural comparison of uterine leiomyoma cells from the same myoma nodule before and after gonadotropin-releasing hormone agonist treatment | Q57188648 | ||
| Variation in the Incidence of Uterine Leiomyoma Among Premenopausal Women by Age and Race | Q57751559 | ||
| Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle | Q59650550 | ||
| Lack of evidence from HPLC 32P-post-labelling for tamoxifenDNA adducts in the human endometrium | Q61774306 | ||
| Steroid hormone receptors compete for factors that mediate their enhancer function | Q61818663 | ||
| The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice | Q67369155 | ||
| Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause | Q68136434 | ||
| Estradiol and 20alpha-dihydroprogesterone dehydrogenase activities in human endometrium during the menstrual cycle | Q68675945 | ||
| The effect of progestins on the mitotic activity of uterine fibromyomas | Q69954738 | ||
| Mitotic activity in uterine leiomyomas during the menstrual cycle | Q69972772 | ||
| Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium | Q70053085 | ||
| Patterns of growth of uterine leiomyomas during pregnancy. A prospective longitudinal study | Q70195122 | ||
| Pregnancy success following surgical correction of imperforate hymen and complete transverse vaginal septum | Q70354833 | ||
| An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial | Q70723071 | ||
| A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri | Q70735247 | ||
| Aromatase expression in endometriosis | Q70871309 | ||
| Endometriosis and pelvic pain: relation to disease stage and localization | Q70911703 | ||
| The effects of hormone replacement therapy on uterine fibroids in postmenopausal women | Q70911730 | ||
| Morphological changes in uterine leiomyomas treated by GnRH agonist goserelin | Q70997857 | ||
| The subunit structure of human breast cancer progesterone receptors: characterization by chromatography and photoaffinity labeling | Q71228918 | ||
| Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients | Q71545530 | ||
| In vitro analysis of the hormonal basis for the sexual dimorphism in the embryonic development of the mouse mammary gland | Q71768273 | ||
| Distribution of progesterone receptor, estradiol dehydrogenase, and 20 alpha-dihydroprogesterone dehydrogenase activities in human endometrial glands and stroma: progestin induction of steroid dehydrogenase activities in vitro is restricted to the g | Q72045793 | ||
| A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer | Q72127267 | ||
| Endometriosis | Q72247288 | ||
| Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors | Q72281048 | ||
| Cytosol estrogen and progestin receptor concentrations and 17β-hydroxysteroid dehydrogenase activities in the endometrium and endometriotic tissue: Effects of hormonal treatment | Q72399827 | ||
| Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction | Q72404089 | ||
| Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor | Q33888599 | ||
| Progesterone receptor isoform A but not B is expressed in endometriosis | Q33914347 | ||
| Mammary gland growth and development from the postnatal period to postmenopause: ovarian steroid receptor ontogeny and regulation in the mouse | Q33923663 | ||
| The role of mammary stroma in modulating the proliferative response to ovarian hormones in the normal mammary gland | Q33923751 | ||
| Sequential recruitment of steroid receptor coactivator-1 (SRC-1) and p300 enhances progesterone receptor-dependent initiation and reinitiation of transcription from chromatin | Q33947754 | ||
| Polymorphisms in nucleotide excision repair genes and endometrial cancer risk | Q33958989 | ||
| Recurrent endometrial stromal sarcoma: treatment with a progestin and gonadotropin releasing hormone agonist | Q33959828 | ||
| High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence | Q33963976 | ||
| Pregnancy-related changes in the size of uterine leiomyomas | Q34000199 | ||
| Ulipristal acetate versus leuprolide acetate for uterine fibroids | Q34030475 | ||
| Role of FOXO1A in the regulation of insulin-like growth factor-binding protein-1 in human endometrial cells: interaction with progesterone receptor | Q34049545 | ||
| Role of progesterone in endometrial cancer | Q34095034 | ||
| Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells | Q34137268 | ||
| Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women | Q34140562 | ||
| Breast cancer and hormone-replacement therapy in the Million Women Study | Q34223870 | ||
| Transactivation of steroidogenic acute regulatory protein in human endometriotic stromalcells is mediated by the prostaglandin EP2 receptor | Q34224671 | ||
| The role of the microenvironment in mammary gland development and cancer | Q34241137 | ||
| Ulipristal acetate versus placebo for fibroid treatment before surgery | Q34251134 | ||
| Altered retinoid uptake and action contributes to cell survival in endometriosis. | Q34262490 | ||
| Role of stem cells in human uterine leiomyoma growth | Q34263429 | ||
| Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. | Q34281611 | ||
| Cancer without disease. | Q34301350 | ||
| Treatment of endometriosis | Q34320226 | ||
| Uterine epithelial estrogen receptor α is dispensable for proliferation but essential for complete biological and biochemical responses | Q34320366 | ||
| Sex steroidal regulation of uterine leiomyoma growth and apoptosis | Q34320465 | ||
| Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor | Q34378783 | ||
| Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer | Q34392493 | ||
| Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells. | Q34463159 | ||
| Aromatase inhibitors: the next generation of therapeutics for endometriosis? | Q34519101 | ||
| Angiogenic factors in endometriosis. | Q34597482 | ||
| Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects | Q34617725 | ||
| Two pathogenetic types of endometrial carcinoma | Q34713298 | ||
| Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin | Q34758422 | ||
| Breast cancer after use of estrogen plus progestin in postmenopausal women | Q34938322 | ||
| COX-2 inhibitors and their role in gynecology | Q35006858 | ||
| Mechanism of action of progesterone antagonists | Q35027291 | ||
| Tissue interaction in androgen response of embryonic mammary rudiment of mouse: identification of target tissue for testosterone | Q35035898 | ||
| Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth | Q39623809 | ||
| Steroid hormones and endometrial cancer | Q39773771 | ||
| High concentrations of progesterone and mifepristone mutually reinforce cell cycle retardation and induction of apoptosis. | Q39857096 | ||
| Early effects of high concentrations of progesterone and mifepristone A gene expression study of endometrial cancer cells (Ishikawa). | Q39896392 | ||
| Induction of Human Endometrial Estradiol Dehydrogenase by Progestins | Q39962020 | ||
| Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone | Q40045161 | ||
| Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways. | Q40144666 | ||
| Histone deacetylase inhibition and progesterone act synergistically to stimulate baboon glycodelin gene expression | Q40163029 | ||
| Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist | Q40202330 | ||
| Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin. | Q40215090 | ||
| Growth regulation and transcriptional activities of estrogen and progesterone in human endometrial cancer cells | Q40323481 | ||
| Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function. | Q40341667 | ||
| Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin | Q40381321 | ||
| The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells | Q40394641 | ||
| Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology. | Q40488240 | ||
| RU486: pharmacology and potential use in the treatment of endometriosis and leiomyomata uteri. | Q40675975 | ||
| Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines | Q40679032 | ||
| Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells | Q40758221 | ||
| Hysterectomy in the United States, 1988-1990. | Q41037526 | ||
| Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). | Q41084288 | ||
| Abnormal ribosome assembly in a mutant of Escherichia coli | Q41129147 | ||
| Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature | Q41331490 | ||
| Endometrial cancer: incidence, prognostic factors, diagnosis, and treatment | Q41358328 | ||
| RU486 (mifepristone): mechanisms of action and clinical uses | Q41360492 | ||
| Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function | Q41523742 | ||
| Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action | Q41546396 | ||
| Physiological action of progesterone in target tissues | Q41574892 | ||
| Does disruption of immune and endocrine systems by environmental toxins contribute to development of endometriosis? | Q41651724 | ||
| Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells | Q41674994 | ||
| Paracrine regulation of epithelial progesterone receptor and lactoferrin by progesterone in the mouse uterus | Q41726031 | ||
| Longitudinal evaluation of uterine myoma growth during pregnancy. A sonographic study | Q42032538 | ||
| Progesterone induces adult mammary stem cell expansion | Q42471079 | ||
| The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity | Q72413179 | ||
| The predisposing gene of the Eker rat inherited cancer syndrome is tightly linked to the tuberous sclerosis (TSC2) gene | Q72692517 | ||
| Use of progestational agents in the management of endometrial cancer | Q72727579 | ||
| Estrogen receptor expression of benign breast epithelium and its association with breast cancer | Q72785661 | ||
| P433 | issue | 1 | |
| P921 | main subject | endometriosis | Q205764 |
| uterine fibroid | Q556281 | ||
| endometrial cancer | Q944777 | ||
| P304 | page(s) | 130-162 | |
| P577 | publication date | 2013-01-09 | |
| P1433 | published in | Endocrine Reviews | Q3054007 |
| P1476 | title | Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer | |
| P478 | volume | 34 |
| Q91655319 | A calcium-dependent phospholipase A2 (cPLA2) expression is regulated by MIG-6 during endometrial tumorigenesis |
| Q47119285 | A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids |
| Q91619806 | A-Kinase Anchoring Protein 13 (AKAP13) Augments Progesterone Signaling in Uterine Fibroid Cells |
| Q37225222 | ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas |
| Q53224664 | ATM may be a protective factor in endometrial carcinogenesis with the progesterone pathway. |
| Q34664105 | Altered gene expression patterns during the initiation and promotion stages of neonatally diethylstilbestrol-induced hyperplasia/dysplasia/neoplasia in the hamster uterus |
| Q47824474 | Androgens Upregulate Endometrial Epithelial Progesterone Receptor Expression: Potential Implications for Endometriosis. |
| Q26749272 | Aromatase expression and regulation in breast and endometrial cancer |
| Q49787688 | Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy |
| Q37001517 | Association between the CYP11 family and six cancer types |
| Q90134710 | Baicalein Is a Phytohormone that Signals Through the Progesterone and Glucocorticoid Receptors |
| Q37685866 | Benign breast and gynecologic conditions, reproductive and hormonal factors, and risk of thyroid cancer |
| Q34568706 | Bioinformatic analysis of cis-regulatory interactions between progesterone and estrogen receptors in breast cancer. |
| Q52683168 | Bisphenol A impairs decidualization of human uterine stromal fibroblasts. |
| Q35614080 | Breast cancer in the setting of fertility-sparing treatment for endometrial cancer |
| Q33776694 | COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration |
| Q92500366 | Chronic Exposure of Mice to Bisphenol-A Alters Uterine Fibroblast Growth Factor Signaling and Leads to Aberrant Epithelial Proliferation |
| Q29248520 | Chronic exposure to bisphenol a impairs progesterone receptor-mediated signaling in the uterus during early pregnancy |
| Q37596751 | Combination of Diane-35 and Metformin to Treat Early Endometrial Carcinoma in PCOS Women with Insulin Resistance |
| Q47911011 | Conditional Ablation of Progesterone Receptor Membrane Component 2 Causes Female Premature Reproductive Senescence |
| Q37353846 | Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial |
| Q38892949 | Correlation Between the Clinical Parameters and Tissue Phenotype in Patients Affected by Deep-Infiltrating Endometriosis |
| Q92237242 | Curcumin and endometrial carcinoma: an old spice as a novel agent |
| Q33711732 | Deep sequencing reveals new aspects of progesterone receptor signaling in breast cancer cells |
| Q36528223 | Deficiency in DGCR8-dependent canonical microRNAs causes infertility due to multiple abnormalities during uterine development in mice. |
| Q92702753 | Development of A 3D Tissue Slice Culture Model for the Study of Human Endometrial Repair and Regeneration |
| Q53440345 | Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus. |
| Q33675285 | Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma. |
| Q38663754 | Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. |
| Q46019835 | Effects of noncavity-distorting fibroids on endometrial gene expression and function. |
| Q36525065 | Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution. |
| Q30353001 | Endometrial Expression of Steroidogenic Factor 1 Promotes Cystic Glandular Morphogenesis. |
| Q37567264 | Endometrial progesterone resistance and PCOS. |
| Q40290088 | Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses |
| Q40645330 | Endometriosis and risks for ovarian, endometrial and breast cancers: A nationwide cohort study. |
| Q35944399 | Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. |
| Q38788210 | Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences |
| Q92702483 | Epigenetic Dysregulation at the Crossroad of Women's Cancer |
| Q64964271 | Epithelial to Mesenchymal Transition and Cell Biology of Molecular Regulation in Endometrial Carcinogenesis. |
| Q34776859 | Establishment of human patient-derived endometrial cancer xenografts in NOD scid gamma mice for the study of invasion and metastasis |
| Q36267111 | Estrogen Receptor β Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis |
| Q34395170 | Fenretinide: a novel treatment for endometrial cancer |
| Q49250031 | Gefitinib enhances sensitivity of endometrial cancer cells to progestin therapy via dual-specificity phosphatase 1. |
| Q58604035 | Generation of Progesterone-Responsive Endometrial Stromal Fibroblasts from Human Induced Pluripotent Stem Cells: Role of the WNT/CTNNB1 Pathway |
| Q37016586 | Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib |
| Q28294446 | HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT |
| Q36054376 | History of uterine leiomyomata and incidence of breast cancer |
| Q64064494 | Hormonal therapy in uterine sarcomas |
| Q30370194 | Hyperplasia and fibrosis in mice with conditional loss of the TSC2 tumor suppressor in Müllerian duct mesenchyme-derived myometria. |
| Q28292646 | Hypomethylation of ETS transcription factor binding sites and upregulation of PARP1 expression in endometrial cancer |
| Q34876165 | Identification and characterization of progesterone- and estrogen-regulated MicroRNAs in mouse endometrial epithelial cells. |
| Q41815158 | Imiquimod Induces Apoptosis in Human Endometrial Cancer Cells In vitro and Prevents Tumor Progression In vivo |
| Q36723027 | Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa |
| Q38648524 | Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer. |
| Q40170713 | In silico, in vitro and in vivo analysis identifies a potential role for steroid hormone regulation of FOXD3 in endometriosis-associated genes |
| Q35617565 | Influence of AKT on progesterone action in endometrial diseases |
| Q52751765 | Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer. |
| Q34504377 | Innovations in classical hormonal targets for endometriosis |
| Q30381117 | Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors. |
| Q28260010 | Kaempferol Exhibits Progestogenic Effects in Ovariectomized Rats |
| Q36324375 | Lack of cyclical fluctuations of endometrial GLUT4 expression in women with polycystic ovary syndrome: Evidence for direct regulation of GLUT4 by steroid hormones |
| Q33826091 | Loss of CDH1 and Pten accelerates cellular invasiveness and angiogenesis in the mouse uterus. |
| Q36000984 | Loss of Cdh1 and Trp53 in the uterus induces chronic inflammation with modification of tumor microenvironment |
| Q47634931 | MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells |
| Q40045531 | Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials |
| Q37658616 | Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials |
| Q26472029 | Metformin for endometrial hyperplasia |
| Q36105494 | Metformin for endometrial hyperplasia: a Cochrane protocol |
| Q51648368 | Metformin targeting autophagy overcomes progesterone resistance in endometrial carcinoma. |
| Q51290637 | Mig-6 Mouse Model of Endometrial Cancer. |
| Q33631557 | Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios? |
| Q38103751 | Model of tumor-associated epigenetic changes of HER2, ER, and PgR expression in invasive breast cancer phenotypes |
| Q28076023 | Molecular Targets and Emerging Therapeutic Options for Uterine Leiomyosarcoma |
| Q33734466 | Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro |
| Q36107514 | Neonatal Progesterone Programs Adult Uterine Responses to Progesterone and Susceptibility to Uterine Dysfunction |
| Q41634189 | Niclosamide As a Potential Nonsteroidal Therapy for Endometriosis That Preserves Reproductive Function in an Experimental Mouse Model. |
| Q37316692 | Oestrogen-induced angiogenesis and implantation contribute to the development of parasitic myomas after laparoscopic morcellation |
| Q34437666 | Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications. |
| Q37516309 | PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma |
| Q53092574 | PRL-3 Is Involved in Estrogen- and IL-6-Induced Migration of Endometrial Stromal Cells From Ectopic Endometrium. |
| Q33779337 | Patients with uterine leiomyoma exhibit a high incidence but low mortality rate for breast cancer. |
| Q47282567 | Pharmacokinetic drug evaluation of ulipristal acetate for the treatment of uterine fibroids. |
| Q57286101 | Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers |
| Q28550351 | Prediction of Candidate Drugs for Treating Pancreatic Cancer by Using a Combined Approach |
| Q36791086 | Primary extraosseous Ewing sarcoma of the lung in children |
| Q35108906 | Progesterone action in breast, uterine, and ovarian cancers |
| Q88032097 | Progesterone activation of zebrafish mineralocorticoid receptor may influence growth of some transplanted tumors |
| Q90073087 | Progesterone and Breast Cancer |
| Q35974555 | Progesterone antagonizes the positive influence of estrogen on Chlamydia trachomatis serovar E in an Ishikawa/SHT-290 co-culture model |
| Q40799076 | Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients. |
| Q49487934 | Progesterone modulates microtubule dynamics and epiboly progression during zebrafish gastrulation. |
| Q37718405 | Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1. |
| Q90412314 | Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma |
| Q37406760 | Progesterone receptor isoforms A and B: new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma |
| Q36844266 | Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors |
| Q35551056 | Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus |
| Q51616209 | Progesterone-induced miR-133a inhibits the proliferation of endometrial epithelial cells. |
| Q30836342 | Progesterone-targeted magnetic resonance imaging probes |
| Q60044628 | Prognostic value of progesterone receptor in solid pseudopapillary neoplasm of the pancreas: evaluation of a pooled case series |
| Q36250770 | Promising clinical practices of metformin in women with PCOS and early-stage endometrial cancer. |
| Q42371820 | Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer |
| Q37725437 | RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer |
| Q33852886 | Recent Advances in Uterine Fibroid Etiology |
| Q36352719 | Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome |
| Q38184989 | Regulation of voltage-gated sodium channel expression in cancer: hormones, growth factors and auto-regulation |
| Q48074431 | Renovated (nondual) approach to endometrial cancer typing: endocrine and inflammatory issues |
| Q64914914 | Role of erythropoietin and its receptor in the development of endometriosis in rats |
| Q34448400 | Role of nuclear progesterone receptor isoforms in uterine pathophysiology |
| Q37361130 | Role of nuclear receptors in blastocyst implantation. |
| Q36447481 | Role of the steroidogenic acute regulatory protein in health and disease |
| Q35855640 | Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy |
| Q29247892 | Strain-Specific Induction of Endometrial Periglandular Fibrosis in Mice Exposed During Adulthood to the Endocrine Disrupting Chemical Bisphenol A |
| Q91779264 | TRPM7 is involved in acid-induced necrotic cell death in a manner sensitive to progesterone in human cervical cancer cells |
| Q35921030 | Targeting female hormone receptors as cervical cancer therapy |
| Q37621100 | Targeting nuclear receptors with marine natural products |
| Q26853244 | The Krüppel-like factors in female reproductive system pathologies |
| Q52799875 | The allosteric AKT inhibitor, MK2206, decreases tumor growth and invasion in patient derived xenografts of endometrial cancer. |
| Q92324480 | The cost-effective, but forgotten, medical endometriosis therapy: a prospective, quasi-randomized study on progestin therapy |
| Q33926671 | The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesis |
| Q59046724 | Theories on the pathogenesis of endometriosis |
| Q33888331 | Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model |
| Q54330083 | Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort. |
| Q36742639 | Unremitting cell proliferation in the secretory phase of eutopic endometriosis: involvement of pAkt and pGSK3β |
| Q35662059 | Use of depot medroxyprogesterone acetate and prevalent leiomyoma in young African American women |
| Q53078772 | Uterine function in the mouse requires speckle-type poz protein. |
| Q30490853 | Vaginal estrogen: a dual-edged sword in postoperative healing of the vaginal wall. |
| Q90559037 | Water-Soluble Nanoconjugate for Enhanced Cellular Delivery of Receptor-Targeted Magnetic Resonance Contrast Agents |
| Q34590328 | Women with endometriosis have a higher DNA repair capacity and diminished breast cancer risk |
Search more.